306
Views
117
CrossRef citations to date
0
Altmetric
Research Article

Drug Targeting by Solid Lipid Nanoparticles for Dermal Use

, , , , , & show all
Pages 489-495 | Published online: 30 Sep 2008

  • Bonnekoh, B., Röding, J., Krueger, G.R., Ghyczy, M. and Mahrle, G. (1991) "Increase of lipid fluidity and suppression of proliferation resulting from liposome uptake by human keratinocytes in vitro", Br. J. Dermatol. 124, 333-340.
  • Gysler, A., Lange, K., Korting, H.C. and Schäfer-Korting, M. (1997) "Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts". Pharm. Res. 14, 793-797.
  • Gysler, A., Kleuser, B., Sippl, W., Lange, K., Korting, H.C., Höltje, H.D. and Schäfer-Korting, M. (1999a) "Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin". Pharm. Res. 16, 1386-1391.
  • Gysler, A., Königsmann, U. and Schäfer-Korting, M. (1999b) "Dreidimensionale Hautmodelle zur Erfassung der perkutanen Resorption", ALTEX 16, 67-72.
  • Jenning, V., Müller, R.H. and Gohla, S. (1998) Solid lipid nanoparticles (SLN): Effect of homogenization parameters on drug stability. 2nd World Meeting APGI/APV, pp. 619-620, Paris.
  • Jenning, V., Hildebrand, G.E., Gysler, A., Müller, R.H. and Schäfer-Korting, M. (1999) "Solid lipid nanoparticles (SLN?) for topical application: occlusive properties". Proc. Int. Symp. Control. ReI. Bioact. Mater. 26, 405-406.
  • Jenning, V., Gysler, A., Schäfer-Korting, M. and Gohla, S. (2000a) "Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug penetration to the upper skin". Eur. J. Pharm. Biopharm. 49, 211-218.
  • Jenning, V., Schäfer-Korting, M. and Gohla, S. (2000b) "Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties", J. Control. Release 66, 115-126.
  • Korting, H.C., Unholzer, A., Schäfer-Korting, M., Tausch, I., Gaßmueller, J. and Nietsch, K.-H. (2002) "Different skin thinning potential of equipotent medium-strength glucocorticoids", Skin Pharmacol. Appl. Skin Physiol. 15, 85-91.
  • van Kuijk-Meuwissen, M.E., Junginger, H.E. and Bouwstra, J.A. (1998a) "Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study", Biochim. Biophys. Acta 1371, 31-39.
  • van Kuijk-Meuwissen, M.E., Mougin, L., Junginger, H.E. and Bouwstra, J.A. (1998b) "Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study", J. Control. Release 56, 189-196.
  • Lange, K., Gysler, A., Bader, M., Kleuser, B., Korting, H.C. and Schäfer- Korting, M. (1997) "Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro", Pharm. Res. 14, 1744-1749.
  • Lange, K., Kleuser, B., Gysler, A., Bader, M., Maia, C., Scheidereit, C. Korting, H.C. and Schäfer-Korting, M. (2000) "Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids", Skin Pharmacol, Appl. Skin Physiol. 13, 93-103.
  • Liebsch, M., Traue, D., Barrabas, C., Spielmann, H., Uphill, P., Wilkins, S., McPherson, J.P., Wiemann, C., Kaufmann, T., Remmele, M. and Holzhütter, H.G. (2000) "The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing", ATLA 28, 371-401.
  • Müller, R.M. and Dingler, A. (1998) "The next generation after the liposomes: solid lipid nanoparticles (SLN/lipopearls) as dermal carriers in cosmetics", EuroCosmetics 7, 19-26.
  • Müller, R.H., Mehnert, W., Lucks, J.-S., Schwarz, C. zur Mühlen, A., Weyhers, H., Freitas, C. and Rühl, D. (1995) "Solid lipid nanoparticles (SLN) - an alternative colloidal drug carrier system for controlled drug delivery", Eur J. Pharm. Biopharm. 41, 62-69.
  • Schackert, C., Korting, H.C. and Schäfer-Korting, M. (2000) "Qualitative and quantitative assessment of the benefit/risk ratio of medium potent topical glucocorticoids in-vitro and in-vivo: characterization of drugs with an improved benefit/risk ratio", BioDrugs 13, 267-272.
  • Schäfer-Korting, M., Korting, H.C., Kerscher, M.J. and Lenhard, S. (1993) "Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids". Clin. Pharmacol. Ther. 54, 448-456.
  • Schaller, M., Steinle, R. and Korting, H.C. (1997) "Light and electron microscopic findings in human epidermis reconstructed in vitro upon topical application of liposomal tretinoin". Acta Derm. Venereol. 77, 122-126.
  • Schaller, M., Preidel, H., Januschke, E. and Korting, H.C. (1999) "Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations". J. Drug Target. 6, 361-372.
  • Speiser, P.P. (1991) "Nanoparticles and liposomes: a state of the art". Methods Find. Exp. Clin. Pharmacol. 13, 337-342.
  • Van der Meer, J.B., Glazenburg, E.J., Mulder, P.G.H., Eggink, H.F. and Coenraads, P.J. (1999) "The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate". Br. J. Dermatol. 140, 1114-1121.
  • Veien, N.K., Olholm Larsen, P. Thestrup-Pedersen, K. and Schon, G. (1999) "Long-term intermittent treatment of chronic hand eczema with mometasone furoate". Br. J. Dermatol. 140, 882-886.
  • Wagner, H., Kostka, K.-H., Lehr, C.-M. and Schaefer, U. (2001) "Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents". J. Control. Release 75, 283-295.
  • Zur Mühlen, A., Schwartz, C. and Mehnert, W. (1998) "Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism". Eur. J. Pharm. Biopharm. 45, 149-155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.